Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

501

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Macular Degeneration
Interventions
DRUG

Macugen

Intravitreal injection of Macugen 0.3mg/90ul every 6 weeks.

Trial Locations (68)

1200

Pfizer Investigational Site, Brussels

1430

Pfizer Investigational Site, Limassol

2300

Pfizer Investigational Site, Turnhout

2500

Pfizer Investigational Site, Lier

6000

Pfizer Investigational Site, Charleroi

6400

Pfizer Investigational Site, Sønderborg

8900

Pfizer Investigational Site, Ieper

10034

Pfizer Investigational Site, Prague

10672

Pfizer Investigational Site, Athens

11526

Pfizer Investigational Site, Athens

13285

Pfizer Investigational Site, Marseille

15706

Pfizer Investigational Site, Santiago de Compostela

18454

Pfizer Investigational Site, Nikaia

20052

Pfizer Investigational Site, Monza, MI

21055

Pfizer Investigational Site, Dijon

28040

Pfizer Investigational Site, Madrid

28041

Pfizer Investigational Site, Arona, NO

28805

Pfizer Investigational Site, Alcalá de Henares

31008

Pfizer Investigational Site, Pamplona

35033

Pfizer Investigational Site, Rennes

38010

Pfizer Investigational Site, Santa Cruz de Tenerife

38100

Pfizer Investigational Site, Grenoble

40138

Pfizer Investigational Site, Bologna

45500

Pfizer Investigational Site, Ioannina

46014

Pfizer Investigational Site, Valencia

46015

Pfizer Investigational Site, Valencia

47010

Pfizer Investigational Site, Valladolid

48145

Pfizer Investigational Site, Münster

53100

Pfizer Investigational Site, Siena

54636

Pfizer Investigational Site, Thessaloniki

54642

Pfizer Investigational Site, Thessaloniki

56124

Pfizer Investigational Site, Pisa

60318

Pfizer Investigational Site, Frankfurt

67063

Pfizer Investigational Site, Ludwigshafen

71001

Pfizer Investigational Site, Heraklion

71110

Pfizer Investigational Site, Heraklion

74370

Pfizer Investigational Site, Argonay

76137

Pfizer Investigational Site, Karlsruhe

78462

Pfizer Investigational Site, Konstanz

80131

Pfizer Investigational Site, Napoli

81675

Pfizer Investigational Site, München

82362

Pfizer Investigational Site, Weilheim

86156

Pfizer Investigational Site, Augsburg

625 00

Pfizer Investigational Site, Brno

500 05

Pfizer Investigational Site, Hradec Králové

304 60

Pfizer Investigational Site, Pilsen

128 08

Pfizer Investigational Site, Prague

169 02

Pfizer Investigational Site, Prague

06220

Pfizer Investigational Site, Le Golfe Juan

115 27

Pfizer Investigational Site, Athens

Unknown

Pfizer Investigational Site, Kavala

Pfizer Investigational Site, Waterford

09100

Pfizer Investigational Site, Cagliari

02100

Pfizer Investigational Site, Rieti

85 - 094

Pfizer Investigational Site, Bydgoszcz

70 - 111

Pfizer Investigational Site, Szczecin

04-141

Pfizer Investigational Site, Warsaw

975 17

Pfizer Investigational Site, Banská Bystrica

826 06

Pfizer Investigational Site, Bratislava

851 03

Pfizer Investigational Site, Bratislava

041 66

Pfizer Investigational Site, Košice

08001

Pfizer Investigational Site, Prešov

081 81

Pfizer Investigational Site, Prešov

03426

Pfizer Investigational Site, Ružomberok

911 71

Pfizer Investigational Site, Trenčín

012 07

Pfizer Investigational Site, Žilina

118 83

Pfizer Investigational Site, Stockholm

721 89

Pfizer Investigational Site, Västerås

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY